SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001174947-24-000523
Filing Date
2024-04-09
Accepted
2024-04-09 11:49:14
Documents
1
Group Members
MARK E. STROMESTROME ALPHA FUND, L.P.STROME GROUP, INC.STROME INVESTMENT MANAGEMENT, LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 7 TO SCHEDULE 13D ea0203503-13da7strome_zivo.htm SC 13D/A 132523
  Complete submission text file 0001174947-24-000523.txt   134506
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Subject) CIK: 0001101026 (see all company filings)

IRS No.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79359 | Film No.: 24831673
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 100 WILSHIRE BLVD., SUITE 1750 SANTA MONICA CA 90401
Business Address 100 WILSHIRE BLVD., SUITE 1750 SANTA MONICA CA 90401 3109176600
STROME MEZZANINE FUND, LP (Filed by) CIK: 0001713153 (see all company filings)

IRS No.: 272464666 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A